Mass Tort & MDL Plaintiff Funding in Florida

Florida sets a four-year limitations period for an injury claim founded on a product's design, manufacture, distribution, or sale (Fla. Stat. §95.11(3)(d)), distinct from the two-year general negligence period the state's 2023 tort-reform law (HB 837) set for ordinary claims under §95.11(5)(a) — the four-year product-specific period governs most mass tort claims. Florida separately imposes a 12-year statute of repose for products generally (Fla. Stat. §95.031(2)(b)), with exceptions directly relevant to a mass tort fact pattern: manufacturer concealment of a known defect, an injury that did not manifest until after the repose period even though exposure occurred within it, and an extended repose period matching a manufacturer warranty longer than 10 years.

Florida applies modified comparative fault with a 51% bar (Fla. Stat. §768.81), extended to virtually all negligence-based actions by the 2023 tort-reform law, and Florida courts have applied comparative-fault principles to strict-liability claims consistent with the state's adoption of strict products liability in West v. Caterpillar Tractor Co., 336 So. 2d 80 (Fla. 1976) — a framework that, as in other comparative-fault states, is frequently built into a mass tort settlement matrix's point categories rather than litigated individually.

Florida has no general statutory cap on compensatory damages in a mass tort action; the Florida Supreme Court struck down the state's medical-malpractice non-economic damages cap in North Broward Hospital District v. Kalitan, 219 So. 3d 49 (Fla. 2017), and mass tort claims have no separate cap of their own.

Pre-judgment interest is generally unavailable on unliquidated tort damages in Florida prior to verdict; a claim resolved through a global settlement matrix instead receives an allocated award rather than a judgment carrying statutory interest.

A Florida mass tort claim filed in or removable to federal court can be transferred to a federal MDL under 28 U.S.C. §1407 for coordinated pretrial proceedings. Florida does not maintain a single, nationally prominent state-level mass tort coordination program comparable to New Jersey's or Pennsylvania's; related Florida state-court cases are more commonly coordinated informally between judges or, in some circuits, through a complex-litigation division, so many Florida-filed mass tort claims proceed primarily through the federal MDL track instead.

Florida has no dedicated consumer litigation funding statute. No statutory cap.

Why does Florida's four-year product-specific deadline matter more than the widely discussed two-year HB 837 change for a mass tort claim?

HB 837 shortened Florida's general negligence limitations period to two years, but the product-specific provision governing design, manufacturing, and warning-defect claims — the theory underlying most mass torts — sits in its own subsection and retains a four-year period, so a Florida mass tort claim should not be assumed time-barred based on the shorter, more publicized general rule.

This distinction is directly relevant to funding timing: a Florida plaintiff evaluating whether to join a mass tort years after their injury may still be well within the controlling four-year window even though the two-year figure is what circulates most widely in public discussion of the 2023 reform.

How does Florida's 12-year repose period interact with a mass tort involving an older product or long-term exposure?

The repose period runs from delivery to the first purchaser and can cut off a claim regardless of injury date, but Florida's exceptions — manufacturer concealment, a longer express warranty, and late-manifesting harm from exposure that occurred within the repose window — are all fact patterns that commonly arise in exactly the kind of long-latency, concealment-driven litigation that produces a mass tort in the first place.

A Florida mass tort plaintiff whose product or exposure falls near or past the 12-year mark needs an early check for which of these exceptions applies, since the underlying mass tort's own litigation history often develops exactly the concealment evidence needed to support that exception for the broader plaintiff population, not just the individual claim.